Preventing endophthalmitis

Endophthalmitis

Volumn , Issue , 2016, Pages 261-278

  Durand, Marlene L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84978221113     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-29231-1_15     Document Type: Chapter

References (54)

1. Combey de Lambert A, Campolmi N, Cornut PL, et al. Baseline factors predictive of visual prognosis in acute postoperative bacterial endophthalmitis in patients undergoing cataract surgery. JAMA Ophthalmol. 2013;131:1159-66.
2. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769-75.
3. Mork P. Polyvinylpyrrolidone-iodine as a disinfectant in eye surgery for five years. Acta Ophthalmol. 1987;65:572-4.
4. Carrim ZI. The efficacy of 5% povidone-iodine for 3 minutes prior to cataract surgery. Eur J Ophthalmol. 2009;19:560-4.
5. Shimada H. Reduction of vitreous contamination rate after 25-gauge vitrectomy by surface irrigation with 0.25% povidone-iodine. Retina. 2013;33:143-51.
6. Li B. Comparison of the topical efficacy of 1%, 5%, 10% povidone-iodine irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg. 2013;39:994-1001.
7. Nentwich MM. Incidence of postoperative endophthalmitis from 1990-2009 using povidoneiodine but no intracameral antibiotics at a single institution. J Cataract Refract Surg. 2015;41:58-66.
8. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978-88.
9. Räen M, Falleth Sandvik G, Drolsum L. Endophthalmitis following cataract surgery: the role of prophylactic postoperative chloramphenicol eye drops. Acta Ophthalmol. 2013;91:118-22.
10. Behndig A, Montan P, Stenevi U, et al. One million cataract surgeries: Swedish National Cataract Register 1992-2009. J Cataract Refract Surg. 2011;37:1539-45.
11. Friling E, Lundstrom M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39:15-21.
12. Barry P. Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery. J Cataract Refract Surg. 2014;40:138-42.
13. Rahman N, Murphy CC. Impact of intracameral cefuroxime on the incidence of postoperative endophthalmitis following cataract surgery in Ireland. Ir J Med Sci. 2015;184:395-8.
14. Chang DF, Braga-Mele R, Henderson BA, et al. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41:1300-5.
15. Kessel L, Flesner P, Andressen J, et al. Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. Acta Ophthalmol. 2015;93:303-17.
16. Storey P, Dollin M, Rayess N, et al. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection. Graefes Arch Clin Exp Ophthalmol. 2016;254:235-42.
17. Sigford DK, Reddy S, Mollineaux C, Schaal S. Global reported endophthalmitis risk following intravitreal injections of anti-BEGF: a literature review and analysis. Clin Ophthalmol. 2015;9:773-81.
18. Fileta JB, Scott IU, Flynn Jr HW. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina. 2014;45:143-9.
19. McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31:654-61.
20. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1-17.
21. Lalwani GA, Flynn Jr HW, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology. 2008;115:473-6.
22. Gower EW, Keay LJ, Stare DE, et al. Characteristics of endophthalmitis after cataract surgery in the United States Medicare Population. Ophthalmology. 2015;122:1625-32.
23. Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina. 2011;31:1525-33.
24. Simunovic MP, Rush RB, Hunyor AP, et al. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol. 2012;96:862-6.
25. Garg SJ, Dollin M, Storey P, et al. Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy. Retina. 2016;36:351-9.
26. McLure HA, Talboys CA, Yentis SM, et al. Surgical face masks and downward dispersal of bacteria. Anaesthesia. 1998;53:624-6.
27. Wen JC, McCannel CA, mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol. 2011;129:1551-4.
28. Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 2012;32:473-6.
29. Brynskov T, Kemp H, Sørensen TL. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting. Retina. 2014;34(5):951-7.
30. Dossarps D, Bron AM, Koehrer P, et al. Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol. 2015;160:17-25.
31. Garg SJ, Dollin M, Hsu J, et al. Effect of a strict “no-talking” policy during intravitreal injection on post-injection endophthalmitis. Ophthalmic Surg Lasers Imaging Retina. 2015;46:1028-34.
32. Andreoli CM, Andreoli MT, Kloek CE, et al. Low rate of endophthalmitis in a large series of open globe injuries. Am J Ophthalmol. 2009;147:601-8.
33. Parke 3rd DW, Pathengay A, Flynn Jr HW, et al. Risk factors for endophthalmitis and retinal detachment with retained intraocular foreign bodies. J Ophthalmol. 2012;2012:758526. doi: 10.1135/2012/738526.
34. Deghani AR, Rezaei L, Salam H, et al. Post traumatic endophthalmitis: incidence and risk factors. Glob J Health Sci. 2014;6:68-72.
35. Kong GY, Henderson RH, Sandhu SS, et al. Wound-related complications and clinical outcomes following open globe injury repair. Clin Experiment Ophthalmol. 2015;43:508-13.
36. Narang S, Gupta V, Gupta A, et al. Role of prophylactic intravitreal antibiotics in open globe injuries. Indian J Ophthalmol. 2003;51:39-44.
37. Soheilian M, Rafati N, Mohebbi MR, et al. Prophylaxis of acute posttraumatic bacterial endophthalmitis: a multicenter, randomized clinical trial of intraocular antibiotic injection, report 2. Arch Ophthalmol. 2007;125:460-5.
38. Ahmed Y, Schimel AM, Pathengay A, et al. Endophthalmitis following open-globe injuries. Eye (Lond). 2012;26:212-7.
39. Taban M, Behrens A, Newcomb RL, et al. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol. 2005;123:605-9.
40. Chen JY, Jones MN, Srinivasan S, et al. Endophthalmitis after penetrating keratoplasty. Ophthalmology. 2015;122:25-30.
41. Wilhelmus KR, Hassan SS. The prognostic role of donor corneoscleral rim cultures in corneal transplantation. Ophthalmology. 2007;114:440-5.
42. Merchant A, Zacks CM, Wilhelmus K, et al. Candida endophthalmitis after keratoplasty. Cornea. 2001;20:226-9.
43. Layer N, Cevallos V, Maxwell AJ, et al. Efficacy and safety of antifungal additives in Optisol-GF corneal storage medium. JAMA Ophthalmol. 2014;132:832-7.
44. Ritterband DC, Shah MK, Meskin SW, et al. Efficacy and safety of voriconazole as an additive in Optisol GS: a preservation medium for corneal donor tissue. Cornea. 2007;26:343-7.
45. Aldave AJ, DeMatteo J, Glasser DB, et al. Report of the Eye Bank Association of America medical advisory board subcommittee on fungal infection after corneal transplantation. Cornea. 2013;32:149-54.
46. Yamamoto T, Sawada A, Mayama C, et al. The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology. 2014;121:1001-6.
47. Vaziri K, Kishor K, Schwartz SG, et al. Incidence of bleb-related endophthalmitis in the United States. Clin Ophthalmol. 2015;9:317-22.
48. Kim EA, Law SK, Coleman AL, et al. Long-term bleb-related infections after trabeculectomy: incidence, risk factors, and influence of a bleb revision. Am J Ophthalmol. 2015;159: 1082-91.
49. Al-Torbak AA, Al-Shahwan S, Al-Jadaan I, et al. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol. 2005;89:454-8.
50. Mandalos A, Tailor R, Parmar T, Sung V. The long-term outcomes of glaucoma drainage device in pediatric glaucoma. J Glaucoma. 2014 October 14 (Epub ahead of print).
51. Gedde SJ, Cscott IU, Tabandeh H, et al. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology. 2001;108:1323-7.
52. Durand ML. Chapter 7: Eye infections. In: Betts RF, Chapman SW, Penn RL, editors. Reese and Betts’ a practical approach to infectious diseases. Philadelphia: Lippincott Williams and Wilkins; 2003. p. 222-50.
53. Seemongal-Dass RR, James TE. Should we vaccinate for glaucoma surgery? Br J Ophthalmol. 2002;86:479-80.
54. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston Keratoprosthesis. Cornea. 2009;28:896-901.